Create a free research account to view current pricing and place an order.
How does Cagrilintide work in research models?
Cagrilintide is an amylin analog pathway compound. Amylin-receptor signaling complements incretin pathways by enhancing satiety, slowing gastric emptying, and supporting meal-size reduction through hindbrain and hypothalamic appetite circuits.
What is the half-life of Cagrilintide?
Half-life: Long acting; context dependent.
Long-acting weekly research profile. Precise pharmacokinetic interpretation depends on formulation and study context; slow escalation is preferred due to additive appetite and nausea effects.
Research dosing reference
0.25-2.4 mg once weekly; slow escalation due to additive nausea potential.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 0.25 mg | 5 units |
| 0.50 mg | 10 units |
| 1.00 mg | 20 units |
| 2.00 mg | 40 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is Cagrilintide reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Once weekly on a consistent day. Time of day is less important than consistency; choose timing that minimizes nausea disruption.
Beginner escalation
Start at the lowest practical exposure and hold each step long enough to evaluate GI tolerance before increasing.
Side-effect mitigation
Monitor nausea, reflux, constipation, reduced appetite, hydration status, fatigue, and delayed gastric emptying. Slow escalation and hydration/electrolytes are primary mitigation tools.
Stack compatibility
Frequently discussed alongside GLP-pathway protocols; additive nausea and appetite suppression require cautious structure.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Use slow, staged exposure with reassessment every 4-8 weeks, especially if combined with GLP-pathway compounds due to additive satiety and nausea potential.
Frequently asked questions
What is Cagrilintide and how is it studied?
Cagrilintide is an amylin analog pathway compound. Amylin-receptor signaling complements incretin pathways by enhancing satiety, slowing gastric emptying, and supporting meal-size reduction through hindbrain and hypothalamic appetite circuits. Cagrilintide is catalogued in the GLP / Metabolic group of this reference and is studied in laboratory and in-vitro models only.
What is known about the half-life of Cagrilintide?
Reference half-life for Cagrilintide: long acting; context dependent. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal. Every lot of Cagrilintide is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC.
How is Cagrilintide stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is Cagrilintide reconstituted for laboratory work?
The reference reconstitution for the 10 mg vial is 2 mL BAC Water, which gives a concentration of about 5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is Cagrilintide FDA approved?
No. The research-grade Cagrilintide described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration